By Inteledoc Expert Team | 10 min read | Medically reviewed by Dr. Nitin Jain, MBBS, MD EDIC — Inteledoc Medical Advisory Team
Finding a GLP-1 doctor in India is easier than it was two years ago. Finding a genuinely good one — who conducts a proper assessment, manages your programme with real clinical rigour, and gives you the outcomes this class of medicine is capable of producing — requires knowing what to look for. The single most effective filter is the questions you ask before committing. This blog gives you seven specific questions, what a good answer sounds like, and what warning signs to watch for.
Why the Quality of Your GLP-1 Doctor Determines Your Results
GLP-1 medicines — semaglutide, tirzepatide — are powerful clinical tools. In clinical trials conducted under rigorous medical supervision, they produce average weight loss of 15–21% of body weight. In real-world settings without proper supervision, results are often significantly lower — and avoidable side effects are significantly higher. The difference is not the medicine. It is the clinical management.
Dose titration that is rushed causes unnecessary nausea. Prescriptions issued without metabolic assessment miss contraindications and leave biological barriers unaddressed. Programmes without dietary integration produce results that are impressive during treatment but fail to persist afterward. A good GLP-1 doctor does not just write a prescription. They build and manage a complete clinical programme in which the prescription is one element.
✗ THE SHORTCUT THAT UNDERMINES RESULTS
Getting a GLP-1 prescription is the hard part. Once you have it, the rest takes care of itself — the medicine does the work and the doctor's ongoing involvement is just administrative.
Clinical evidence consistently shows that GLP-1 treatment within a supervised programme produces significantly better outcomes than GLP-1 treatment as a standalone prescription. The ongoing medical relationship — dose management, side effect monitoring, dietary integration, plateau management, and transition to maintenance — accounts for a substantial proportion of the clinical benefit. Reducing the doctor’s role to prescription-writing captures only a fraction of what the treatment is capable of delivering.
The 7 Questions — And What the Answers Should Tell You
Question 1 — "What will you assess before prescribing?"
A full medical history, review of current medications, and a blood panel covering at minimum thyroid function, fasting insulin and glucose, HbA1c, liver function, kidney function, and lipid profile — before any prescription is issued.
“We just need a few basic details and we can get you started.”
A prescription issued without comprehensive pre-treatment assessment is a prescription issued without the clinical basis to know it is safe for you.
Question 2 — "How do you manage dose escalation?"
Gradually, based on individual tolerance. Starting at the lowest dose — 0.25mg for semaglutide, 2.5mg for tirzepatide — and increasing only when the current dose is well tolerated. No fixed schedule that ignores individual response.
A fixed escalation schedule applied to all patients regardless of how each individual is responding. Rushed titration is the primary cause of avoidable and discouraging side effects.
Question 3 — "What dietary support is included?"
A personalised diet plan built around your assessment results, metabolic profile, protein targets specific to your body weight, and Indian food culture. Regular dietary review and adjustment as your programme progresses.
A generic diet sheet or a referral to an external nutritionist who is not coordinated with your clinical programme. The diet and the medicine need to be designed together — not operated independently.
Question 4 — "How often will we have clinical check-ins?"
Every two to four weeks during active treatment — with a doctor, not just a support coordinator. More frequently if you are in the early stages of dose escalation or experiencing side effects.
Monthly check-ins at best, or “reach out if you have problems.” Inadequate monitoring frequency means that dose adjustments are delayed, side effects are managed reactively rather than proactively, and plateaus go unaddressed.
Question 5 — "What happens when I hit a plateau?"
A clinical review to identify the specific reason — which may be metabolic adaptation, a hormonal shift, a dietary issue, or a need for dose adjustment — followed by targeted programme modification
“Just keep going, plateaus are normal.” A plateau that persists for more than four to six weeks in a supervised programme warrants clinical investigation, not reassurance.
Question 6 — "What is the long-term plan — including after I stop the medicine?"
A structured maintenance phase built into the programme from the beginning, focused on establishing the dietary and lifestyle habits that sustain results after active treatment ends. A plan for managing the biological rebound risk that clinical evidence shows is real after stopping GLP-1 treatment.
No discussion of maintenance. Programmes focused entirely on the active treatment phase without planning for what follows produce significantly higher weight regain rates.
Question 7 — "What are the specific risks for someone with my health profile?"
A specific, personalised response to your medical history — addressing relevant contraindications, medication interactions, and monitoring considerations for your individual situation.
A generic risk disclaimer rather than a personalised clinical discussion. If the doctor cannot tailor the risk conversation to your specific profile, they do not know your specific profile well enough to be prescribing for you.
✓ HOW INTELEDOC ANSWERS ALL SEVEN
Every Inteledoc patient receives a comprehensive pre-treatment assessment, careful dose titration, personalised dietary integration, fortnightly clinical check-ins with a doctor, proactive plateau management, and a structured maintenance plan. This is the clinical standard that produces the outcomes GLP-1 medicines are capable of. See our programme plans. BOOK YOUR CONSULTATION HERE.
Frequently Asked Questions
At minimum, MBBS registration with the Medical Council of India. Preferably with additional training or practice experience in obesity medicine, endocrinology, or metabolic health — areas where GLP-1 clinical expertise is concentrated. Ask specifically about the doctor’s experience with GLP-1 treatment and the number of patients they have managed on this class of medicine.
A legitimate prescription from an online doctor includes the prescribing doctor’s name, registration number, date, your name, the medicine name and dose, and specific instructions. It is issued on clinical letterhead and is associated with a documented consultation. Inteledoc provides fully documented prescriptions that meet all regulatory requirements.
Generally yes, and weight loss often allows blood pressure medication doses to be reduced over time under doctor supervision. The specific interaction depends on which medications you are taking. This is assessed as part of Inteledoc’s comprehensive medication review at the initial consultation.
Responsiveness between scheduled check-ins is an important quality indicator. Inteledoc provides clear channels for patient communication between consultations — particularly important during early dose escalation when questions and side effect management needs are most likely to arise.
Yes. Inteledoc doctors regularly see patients who have started GLP-1 programmes elsewhere and want a more comprehensive clinical framework around their treatment. Bring your current prescription details and any blood work results to the consultation.
There is no minimum commitment required beyond the initial consultation — which carries no obligation to proceed. Most patients who begin the programme commit to a minimum three month period to allow adequate time for dose titration and meaningful assessment of results.
Yes. Some supplements — particularly high-dose vitamin supplements, herbal preparations, and metabolic supplements — can interact with GLP-1 medicines or affect the interpretation of blood test results. Disclose everything you are taking at your initial consultation.
You can stop at any time — these are not binding commitments. Your doctor will advise on how
to discontinue safely and what to expect in terms of appetite and weight changes after stopping. Early discontinuation is most common when side effects have been poorly managed, which is why good dose titration from the start matters significantly.
Ready to start your doctor-supervised weight loss journey?
Inteledoc — India's first metabolonomics-based weight loss programme. Online & in-person in Gurugram. Plans from ₹1,500/month.
Book a consultation